Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies

Experimental Eye Research

Volumn 93, Issue 2, 2011, Pages 204-212

  Lee, Shanjean ^a   Van Bergen, Nicole J ^a   Kong, George Y ^a   Chrysostomou, Vicki ^a   Waugh, Hayley S ^a   O'Neill, Evelyn C ^a   Crowston, Jonathan G ^a   Trounce, Ian A ^a  

^a CENTRE FOR EYE RESEARCH AUSTRALIA   (Australia)

Author keywords

Glaucoma; Mitochondria; Optic neuropathy; Oxidative phosphorylation; Retinal ganglion cell

Indexed keywords

MITOCHONDRIAL DNA; XENOBIOTIC AGENT;

AGING; ARTICLE; AUTOSOMAL DOMINANT OPTIC ATROPHY; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENETIC RISK; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LEBER HEREDITARY OPTIC NEUROPATHY; MECHANICAL STRESS; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL GENETICS; MITOCHONDRION; OPTIC NERVE DISEASE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RETINA GANGLION CELL; RISK FACTOR;

ANIMALS; ENERGY METABOLISM; GLAUCOMA; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OPTIC NERVE DISEASES; OXIDATIVE PHOSPHORYLATION; RETINAL GANGLION CELLS;

EID: 80052788505     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2010.07.015     Document Type: Article

References (152)

1. Abu-Amero K., Jaber M., Hellani A., Bosley T.M. Genome-wide expression profile of LHON patients with the 11778 mutation. Br. J. Ophthalmol. 2009, 94:256-259.
2. Abu-Amero K.K., Morales J., Bosley T.M. Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2006, 47:2533-2541.
3. Agapova O.A., Kaufman P.L., Hernandez M.R. Androgen receptor and NFkB expression in human normal and glaucomatous optic nerve head astrocytes in vitro and in experimental glaucoma. Exp. Eye Res. 2006, 82:1053-1059.
4. Akiyama T.E., Meinke P.T., Berger J.P. PPAR ligands: potential therapies for metabolic syndrome. Curr. Diab. Rep. 2005, 5:45-52.
5. Alexander C., Votruba M., Pesch U.E., Thiselton D.L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., Bhattacharya S.S., Wissinger B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26:211-215.
6. Amati-Bonneau P., Guichet A., Olichon A., Chevrollier A., Viala F., Miot S., Ayuso C., Odent S., Arrouet C., Verny C., Calmels M.N., Simard G., Belenguer P., Wang J., Puel J.L., Hamel C., Malthiery Y., Bonneau D., Lenaers G., Reynier P. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann. Neurol. 2005, 58:958-963.
7. Amati-Bonneau P., Valentino M.L., Reynier P., Gallardo M.E., Bornstein B., Boissiere A., Campos Y., Rivera H., de la Aleja J.G., Carroccia R., Iommarini L., Labauge P., Figarella-Branger D., Marcorelles P., Furby A., Beauvais K., Letournel F., Liguori R., La Morgia C., Montagna P., Liguori M., Zanna C., Rugolo M., Cossarizza A., Wissinger B., Verny C., Schwarzenbacher R., Martin M.A., Arenas J., Ayuso C., Garesse R., Lenaers G., Bonneau D., Carelli V. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008, 131:338-351.
8. Andrews R.M., Griffiths P.G., Johnson M.A., Turnbull D.M. Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br. J. Ophthalmol. 1999, 83:231-235.
9. Anson R.M., Guo Z., de Cabo R., Iyun T., Rios M., Hagepanos A., Ingram D.K., Lane M.A., Mattson M.P. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:6216-6220.
10. Attardi G., Enriquez J.A., Cabezas-Herrera J. Inter-mitochondrial complementation of mtDNA mutations and nuclear context. Nat. Genet. 2002, 30:360. author reply 361.
11. Aung T., Ocaka L., Ebenezer N.D., Morris A.G., Brice G., Child A.H., Hitchings R.A., Lehmann O.J., Bhattacharya S.S. Investigating the association between OPA1 polymorphisms and glaucoma: comparison between normal tension and high tension primary open angle glaucoma. Hum. Genet. 2002, 110:513-514.
12. Aung T., Ocaka L., Ebenezer N.D., Morris A.G., Krawczak M., Thiselton D.L., Alexander C., Votruba M., Brice G., Child A.H., Francis P.J., Hitchings R.A., Lehmann O.J., Bhattacharya S.S. A major marker for normal tension glaucoma: association with polymorphisms in the OPA1 gene. Hum. Genet. 2002, 110:52-56.
13. Balaratnasingam C., Morgan W.H., Johnstone V., Cringle S.J., Yu D.Y. Heterogeneous distribution of axonal cytoskeleton proteins in the human optic nerve. Invest. Ophthalmol. Vis. Sci. 2009, 50:2824-2838.
14. Barboni P., Savini G., Valentino M.L., Montagna P., Cortelli P., De Negri A.M., Sadun F., Bianchi S., Longanesi L., Zanini M., de Vivo A., Carelli V. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005, 112:120-126.
15. Barish G.D., Narkar V.A., Evans R.M. PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 2006, 116:590-597.
16. Barron M.J., Griffiths P., Turnbull D.M., Bates D., Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br. J. Ophthalmol. 2004, 88:286-290.
17. Barros M.H., Bandy B., Tahara E.B., Kowaltowski A.J. Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae. J. Biol. Chem. 2004, 279:49883-49888.
18. Barsoum M.J., Yuan H., Gerencser A.A., Liot G., Kushnareva Y., Graber S., Kovacs I., Lee W.D., Waggoner J., Cui J., White A.D., Bossy B., Martinou J.C., Youle R.J., Lipton S.A., Ellisman M.H., Perkins G.A., Bossy-Wetzel E. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006, 25:3900-3911.
19. Bastin J., Aubey F., Rotig A., Munnich A., Djouadi F. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J. Clin. Endocrinol. Metab. 2008, 93:1433-1441.
20. Benton C.R., Holloway G.P., Campbell S.E., Yoshida Y., Tandon N.N., Glatz J.F., Luiken J.J., Spriet L.L., Bonen A. Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J. Physiol. 2008, 586:1755-1766.
21. Bordone L., Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell Biol. 2005, 6:298-305.
22. Bristow E.A., Griffiths P.G., Andrews R.M., Johnson M.A., Turnbull D.M. The distribution of mitochondrial activity in relation to optic nerve structure. Arch. Ophthalmol. 2002, 120:791-796.
23. Brown M.D., Allen J.C., Van Stavern G.P., Newman N.J., Wallace D.C. Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations. Am. J. Med. Genet. 2001, 104:331-338.
24. Brown M.D., Trounce I.A., Jun A.S., Allen J.C., Wallace D.C. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. J. Biol. Chem. 2000, 275:39831-39836.
25. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004, 303:2011-2015.
26. Bu X., Rotter J.I. Leber hereditary optic neuropathy: estimation of number of embryonic precursor cells and disease threshold in heterozygous affected females at the X-linked locus. Clin. Genet. 1992, 42:143-148.
27. Bu X.D., Rotter J.I. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:8198-8202.
28. Bui B.V., Fortune B. Ganglion cell contributions to the rat full-field electroretinogram. J. Physiol. 2004, 555:153-173.
29. Buono L.M., Foroozan R., Sergott R.C., Savino P.J. Is normal tension glaucoma actually an unrecognized hereditary optic neuropathy? New evidence from genetic analysis. Curr. Opin. Ophthalmol. 2002, 13:362-370.
30. Butterfield D.A., Howard B.J., Yatin S., Allen K.L., Carney J.M. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:674-678.
31. Cadenas E., Boveris A., Ragan C.I., Stoppani A.O. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 1977, 180:248-257.
32. Cadenas E., Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 2000, 29:222-230.
33. Cakatay U., Telci A., Kayali R., Tekeli F., Akcay T., Sivas A. Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain. Exp. Gerontol. 2001, 36:221-229.
34. Calandrella N., Scarsella G., Pescosolido N., Risuleo G. Degenerative and apoptotic events at retinal and optic nerve level after experimental induction of ocular hypertension. Mol. Cell. Biochem. 2007, 301:155-163.
35. Carelli V., La Morgia C., Valentino M.L., Barboni P., Ross-Cisneros F.N., Sadun A.A. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim. Biophys. Acta 2009, 1787:518-528.
36. Carelli V., Ross-Cisneros F.N., Sadun A.A. Mitochondrial dysfunction as a cause of optic neuropathies. Prog. Retin. Eye Res. 2004, 23:53-89.
37. Chen D., Bruno J., Easlon E., Lin S.J., Cheng H.L., Alt F.W., Guarente L. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008, 22:1753-1757.
38. Chen H., Chan D.C. Critical dependence of neurons on mitochondrial dynamics. Curr. Opin. Cell Biol. 2006, 18:453-459.
39. Chen H., Chomyn A., Chan D.C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 2005, 280:26185-26192.
40. Chen H., McCaffery J.M., Chan D.C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007, 130:548-562.
41. Cheng A.Y., Leiter L.A. PPAR-alpha: therapeutic role in diabetes-related cardiovascular disease. Diabetes Obes. Metab. 2008, 10:691-698.
42. Chevrollier A., Guillet V., Loiseau D., Gueguen N., de Crescenzo M.A., Verny C., Eng M.F., Dollfus H., Odent S., Milea D., Goizet C., Amati-Bonneau P., Procaccio V., Bonneau D., Reynier P. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann. Neurol. 2008, 63:794-798.
43. Cipolat S., Martins de Brito O., Dal Zilio B., Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15927-15932.
44. Civitarese A.E., Carling S., Heilbronn L.K., Hulver M.H., Ukropcova B., Deutsch W.A., Smith S.R., Ravussin E. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 2007, 4:e76.
45. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., Howitz K.T., Gorospe M., de Cabo R., Sinclair D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
46. Cohn A.C., Toomes C., Potter C., Towns K.V., Hewitt A.W., Inglehearn C.F., Craig J.E., Mackey D.A. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am. J. Ophthalmol. 2007, 143:656-662.
47. Corton J.C., Brown-Borg H.M. Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:1494-1509.
48. Crouch P.J., Cimdins K., Duce J.A., Bush A.I., Trounce I.A. Mitochondria in aging and Alzheimer's disease. Rejuvenation Res. 2007, 10:349-357.
49. Delettre C., Griffoin J., Kaplan J., Dollfus H., Lorenz B., Faivre L., Lenaers G., Belenguer P., Hamel C. Mutation spectrum and splicing variants in the OPA1 gene. Hum. Genet. 2001, 109:584-591.
50. Delettre C., Lenaers G., Griffoin J., Gigarel N., Lorenzo C., Belenguer P., Pelloquin L., Grosgeorge J., Turc-Carel C., Perret E., Astarie-Dequeker C., Lasquellec L., Arnaud B., Ducommun B., Kaplan J., Hamel C. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 2000, 26:207-210.
51. Delettre C., Lenaers G., Pelloquin L., Belenguer P., Hamel C.P. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol. Genet. Metab. 2002, 75:97-107.
52. Descamps O., Riondel J., Ducros V., Roussel A.M. Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: effect of alternate-day fasting. Mech. Ageing Dev. 2005, 126:1185-1191.
53. Duvezin-Caubet S., Jagasia R., Wagener J., Hofmann S., Trifunovic A., Hansson A., Chomyn A., Bauer M.F., Attardi G., Larsson N.G., Neupert W., Reichert A.S. Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J. Biol. Chem. 2006, 281:37972-37979.
54. Feige J.N., Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007, 17:292-301.
55. Ferre M., Amati-Bonneau P., Tourmen Y., Malthiery Y., Reynier P. eOPA1: an online database for OPA1 mutations. Hum. Mutat. 2005, 25:423-428.
56. Frezza C., Cipolat S., Martins de Brito O., Micaroni M., Beznoussenko G.V., Rudka T., Bartoli D., Polishuck R.S., Danial N.N., De Strooper B., Scorrano L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126:177-189.
57. Garcia-Valenzuela E., Shareef S., Walsh J., Sharma S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 1995, 61:33-44.
58. Gerhart-Hines Z., Rodgers J.T., Bare O., Lerin C., Kim S.H., Mostoslavsky R., Alt F.W., Wu Z., Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 2007, 26:1913-1923.
59. Gervois P., Torra I.P., Fruchart J.C., Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin. Chem. Lab. Med. 2000, 38:3-11.
60. Graham S., Fortune B. Electrophysiology in glaucoma assessment. Glaucoma, Medical Diagnosis and Therapy 2009, vol. 1:151-171. Saunders Elsevier. T.M. Shaarawy, M.B. Sherwood, R.A. Hitchings, J.G. Crowston (Eds.).
61. Gross B., Staels B. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21:687-710.
62. Guarente L., Picard F. Calorie restriction - the SIR2 connection. Cell 2005, 120:473-482.
63. Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A., Ferrari G., Russo-Marie F., Sillito A.M., Cheetham M.E., Moss S.E., Fitzke F.W., Cordeiro M.F. Targeting amyloid-beta in glaucoma treatment. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13444-13449.
64. Hernandez M.R. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog. Retin. Eye Res. 2000, 19:297-321.
65. Hernandez M.R., Agapova O.A., Yang P., Salvador-Silva M., Ricard C.S., Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia 2002, 38:45-64.
66. Hollander H., Makarov F., Stefani F.H., Stone J. Evidence of constriction of optic nerve axons at the lamina cribrosa in the normotensive eye in humans and other mammals. Ophthalmic Res. 1995, 27:296-309.
67. Hondares E., Pineda-Torra I., Iglesias R., Staels B., Villarroya F., Giralt M. PPARdelta, but not PPARalpha, activates PGC-1alpha gene transcription in muscle. Biochem. Biophys. Res. Commun. 2007, 354:1021-1027.
68. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., Barter J.W., Barbay J.M., Marchant J.K., Mahesh N., Porciatti V., Whitmore A.V., Masland R.H., John S.W. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell Biol. 2007, 179:1523-1537.
69. Hoyt C.S. Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology 1980, 87:245-251.
70. Hudson G., Amati-Bonneau P., Blakely E.L., Stewart J.D., He L., Schaefer A.M., Griffiths P.G., Ahlqvist K., Suomalainen A., Reynier P., McFarland R., Turnbull D.M., Chinnery P.F., Taylor R.W. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008, 131:329-337.
71. Inoue H., Jiang X.F., Katayama T., Osada S., Umesono K., Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci. Lett. 2003, 352:203-206.
72. Ishihara N., Fujita Y., Oka T., Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006, 25:2966-2977.
73. Jahani-Asl A., Cheung E.C., Neuspiel M., MacLaurin J.G., Fortin A., Park D.S., McBride H.M., Slack R.S. Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death. J. Biol. Chem. 2007, 282:23788-23798.
74. Jarrett S.G., Lin H., Godley B.F., Boulton M.E. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog. Retin. Eye Res. 2008, 27:596-607.
75. Jia K., Levine B. Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 2007, 3:597-599.
76. Joseph J.A., Denisova N.A., Bielinski D., Fisher D.R., Shukitt-Hale B. Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention. Mech. Ageing Dev. 2000, 116:141-153.
77. Ju W.K., Kim K.Y., Lindsey J.D., Angert M., Patel A., Scott R.T., Liu Q., Crowston J.G., Ellisman M.H., Perkins G.A., Weinreb R.N. Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells. Mol. Vis. 2009, 15:120-134.
78. Ju W.K., Liu Q., Kim K.Y., Crowston J.G., Lindsey J.D., Agarwal N., Ellisman M.H., Perkins G.A., Weinreb R.N. Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells. Invest. Ophthalmol. Vis. Sci. 2007, 48:2145-2151.
79. Karbowski M., Arnoult D., Chen H., Chan D.C., Smith C.L., Youle R.J. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J. Cell Biol. 2004, 164:493-499.
80. Katano H., Ishihara M., Shiraishi Y., Kawai Y. Effects of aging on the electroretinogram during ischemia-reperfusion in rats. Jpn. J. Physiol. 2001, 51:89-97.
81. Kerrigan L.A., Zack D.J., Quigley H.A., Smith S.D., Pease M.E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch. Ophthalmol. 1997, 115:1031-1035.
82. Kline L.B., Glaser J.S. Dominant optic atrophy. The clinical profile. Arch. Ophthalmol. 1979, 97:1680-1686.
83. Kong G.Y., Van Bergen N.J., Trounce I.A., Crowston J.G. Mitochondrial dysfunction and glaucoma. J. Glaucoma 2009, 18:93-100.
84. Korsten A., de Coo I.F., Spruijt L., de Wit L.E., Smeets H.J., Sluiter W. Patients with Leber hereditary optic neuropathy fail to compensate impaired oxidative phosphorylation. Biochim. Biophys. Acta 2010, 1797:197-203.
85. Kushnareva Y., Murphy A.N., Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem. J. 2002, 368:545-553.
86. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
87. Leske M.C., Heijl A., Hyman L., Bengtsson B., Dong L., Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007, 114:1965-1972.
88. Leung C.K., Lindsey J.D., Crowston J.G., Lijia C., Chiang S., Weinreb R.N. Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy. Invest. Ophthalmol. Vis. Sci. 2008, 49:4898-4902.
89. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., Michael L.F., Puigserver P., Isotani E., Olson E.N., Lowell B.B., Bassel-Duby R., Spiegelman B.M. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801.
90. Liu Q., Ju W.K., Crowston J.G., Xie F., Perry G., Smith M.A., Lindsey J.D., Weinreb R.N. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest. Ophthalmol. Vis. Sci. 2007, 48:4580-4589.
91. Lodi R., Tonon C., Valentino M.L., Iotti S., Clementi V., Malucelli E., Barboni P., Longanesi L., Schimpf S., Wissinger B., Baruzzi A., Barbiroli B., Carelli V. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann. Neurol. 2004, 56:719-723.
92. Lopez-Lluch G., Hunt N., Jones B., Zhu M., Jamieson H., Hilmer S., Cascajo M.V., Allard J., Ingram D.K., Navas P., de Cabo R. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1768-1773.
93. Mabuchi F., Tang S., Kashiwagi K., Yamagata Z., Iijima H., Tsukahara S. The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am. J. Ophthalmol. 2007, 143:125-130.
94. Magistretti P.J. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 2006, 209:2304-2311.
95. Mayorov V., Lowrey A., Biousse V., Newman N., Cline S., Brown M. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy. BMC Biochem. 2008, 9:22.
96. Means L.W., Higgins J.L., Fernandez T.J. Mid-life onset of dietary restriction extends life and prolongs cognitive functioning. Physiol. Behav. 1993, 54:503-508.
97. Minckler D.S., Bunt A.H., Johanson G.W. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest. Ophthalmol. Vis. Sci. 1977, 16:426-441.
98. Miwa S., Lawless C., von Zglinicki T. Mitochondrial turnover in liver is fast in vivo and is accelerated by dietary restriction: application of a simple dynamic model. Aging Cell 2008, 7:920-923.
99. Moreno M.C., Campanelli J., Sande P., Sanez D.A., Keller Sarmiento M.I., Rosenstein R.E. Retinal oxidative stress induced by high intraocular pressure. Free Radic. Biol. Med. 2004, 37:803-812.
100. Munch G., Luth H.J., Wong A., Arendt T., Hirsch E., Ravid R., Riederer P. Crosslinking of alpha-synuclein by advanced glycation endproducts - an early pathophysiological step in Lewy body formation?. J. Chem. Neuroanat. 2000, 20:253-257.
101. Mutsaers S.E., Carroll W.M. Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol. 1998, 96:139-143.
102. Nehlin J.O., Mogensen J.P., Petterson I., Jeppesen L., Fleckner J., Wulff E.M., Sauerberg P. Selective PPAR agonists for the treatment of type 2 diabetes. Ann. N. Y. Acad. Sci. 2006, 1067:448-453.
103. Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., Falcone S., Valerio A., Cantoni O., Clementi E., Moncada S., Carruba M.O. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310:314-317.
104. Olanow C.W. An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol. 1992, 32(Suppl.):S2-S9.
105. Olichon A., Baricault L., Gas N., Guillou E., Valette A., Belenguer P., Lenaers G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 2003, 278:7743-7746.
106. Olichon A., Elachouri G., Baricault L., Delettre C., Belenguer P., Lenaers G. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ. 2007, 14:682-692.
107. Olichon A., Guillou E., Delettre C., Landes T., Arnaune-Pelloquin L., Emorine L.J., Mils V., Daloyau M., Hamel C., Amati-Bonneau P., Bonneau D., Reynier P., Lenaers G., Belenguer P. Mitochondrial dynamics and disease, OPA1. Biochim. Biophys. Acta 2006, 1763:500-509.
108. Osborne N.N. Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma. Exp. Eye Res. 2010, 90:750-757.
109. Papaioannou N., Tooten P.C., van Ederen A.M., Bohl J.R., Rofina J., Tsangaris T., Gruys E. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 2001, 8:11-21.
110. Parker J.A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H., Neri C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 2005, 37:349-350.
111. Pease M.E., McKinnon S.J., Quigley H.A., Kerrigan-Baumrind L.A., Zack D.J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 2000, 41:764-774.
112. Pfister J.A., Ma C., Morrison B.E., D'Mello S.R. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One 2008, 3:e4090.
113. Powell B.L., Toomes C., Scott S., Yeung A., Marchbank N.J., Spry P.G., Lumb R., Inglehearn C.F., Churchill A.J. Polymorphisms in OPA1 are associated with normal tension glaucoma. Mol. Vis. 2003, 9:460-464.
114. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003, 24:78-90.
115. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 1999, 18:39-57.
116. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90:262-267.
117. Quigley H.A., Hohman R.M., Addicks E.M., Massof R.W., Green W.R. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am. J. Ophthalmol. 1983, 95:673-691.
118. Quigley H.A., Nickells R.W., Kerrigan L.A., Pease M.E., Thibault D.J., Zack D.J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 1995, 36:774-786.
119. Raichle M.E., Gusnard D.A. Appraising the brain's energy budget. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:10237-10239.
120. Ray K., Mookherjee S. Molecular complexity of primary open angle glaucoma: current concepts. J. Genet. 2009, 88:451-467.
121. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
122. Rogina B., Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15998-16003.
123. Savini G., Zanini M., Carelli V., Sadun A.A., Ross-Cisneros F.N., Barboni P. Correlation between retinal nerve fibre layer thickness and optic nerve head size: an optical coherence tomography study. Br. J. Ophthalmol. 2005, 89:489-492.
124. Scarpulla R.C. Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 2002, 286:81-89.
125. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88:611-638.
126. Scherz-Shouval R., Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007, 17:422-427.
127. Sohal R.S., Agarwal S., Candas M., Forster M.J., Lal H. Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev. 1994, 76:215-224.
128. Srivastava S., Diaz F., Iommarini L., Aure K., Lombes A., Moraes C.T. PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum. Mol. Genet. 2009, 18:1805-1812.
129. Staels B. PPAR agonists and the metabolic syndrome. Therapie 2007, 62:319-326.
130. Tan L., Yu J.T., Guan H.S. Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha. Med. Hypotheses 2008, 71:664-667.
131. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 2006, 25:490-513.
132. Tezel G. The role of glia, mitochondria, and the immune system in glaucoma. Invest. Ophthalmol. Vis. Sci. 2009, 50:1001-1012.
133. Tezel G., Seigel G.M., Wax M.B. Autoantibodies to small heat shock proteins in glaucoma. Invest. Ophthalmol. Vis. Sci. 1998, 39:2277-2287.
134. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410:227-230.
135. Trounce I., Byrne E., Marzuki S. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet 1989, 1:637-639.
136. Turrens J.F., Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 1980, 191:421-427.
137. Varshavsky A. Regulated protein degradation. Trends Biochem. Sci. 2005, 30:283-286.
138. Virbasius C.A., Virbasius J.V., Scarpulla R.C. NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators. Genes Dev. 1993, 7:2431-2445.
139. Virbasius J.V., Virbasius C.A., Scarpulla R.C. Identity of GABP with NRF-2, a multisubunit activator of cytochrome oxidase expression, reveals a cellular role for an ETS domain activator of viral promoters. Genes Dev. 1993, 7:380-392.
140. Votruba M. Molecular genetic basis of primary inherited optic neuropathies. Eye 2004, 18:1126-1132.
141. Wang A.L., Lukas T.J., Yuan M., Neufeld A.H. Age-related increase in mitochondrial DNA damage and loss of DNA repair capacity in the neural retina. Neurobiol. Aging 2008.
142. Wei Y.H., Lu C.Y., Lee H.C., Pang C.Y., Ma Y.S. Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann. N. Y. Acad. Sci. 1998, 854:155-170.
143. Wenz T. PGC-1alpha activation as a therapeutic approach in mitochondrial disease. IUBMB Life 2009, 61:1051-1062.
144. Wenz T., Diaz F., Spiegelman B.M., Moraes C.T. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 2008, 8:249-256.
145. Wikstrom J.D., Twig G., Shirihai O.S. What can mitochondrial heterogeneity tell us about mitochondrial dynamics and autophagy?. Int. J. Biochem. Cell Biol. 2009, 41:1914-1927.
146. Wolf C., Gramer E., Muller-Myhsok B., Pasutto F., Reinthal E., Wissinger B., Weisschuh N. Evaluation of nine candidate genes in patients with normal tension glaucoma: a case control study. BMC Med. Genet. 2009, 10:91.
147. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
148. Yaffe M.P. The machinery of mitochondrial inheritance and behaviour. Science 1999, 1493-1497.
149. Yang J., Tezel G., Patil R.V., Romano C., Wax M.B. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 2001, 42:1273-1276.
150. Yoshida S., Yashar B.M., Hiriyanna S., Swaroop A. Microarray analysis of gene expression in the aging human retina. Invest. Ophthalmol. Vis. Sci. 2002, 43:2554-2560.
151. Yu D.Y., Cringle S.J. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog. Retin. Eye Res. 2001, 20:175-208.
152. Zanna C., Ghelli A., Porcelli A.M., Karbowski M., Youle R.J., Schimpf S., Wissinger B., Pinti M., Cossarizza A., Vidoni S., Valentino M.L., Rugolo M., Carelli V. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008, 131:352-367.